Vera Therapeutics (VERA) Change in Acquisitions & Divestments (2022 - 2026)

Vera Therapeutics (VERA) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $87.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 17.25% year-over-year to $87.9 million; the trailing twelve-month figure through Mar 2026 stood at $487.8 million (up 39.57% YoY), and the FY2025 full-year result was $506.2 million, up 84.09% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $87.9 million, down from $105.3 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $168.6 million in Q3 2025 and bottomed at $16.0 million in Q2 2022.
• The 5-year median for Change in Acquisitions & Divestments is $65.2 million (2023), against an average of $70.2 million.
• The widest annual swing landed in 2025, when Change in Acquisitions & Divestments jumped 235.36%; it then retreated 17.25% in 2026.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $24.0 million in 2022, then jumped by 199.25% to $71.8 million in 2023, then climbed by 2.03% to $73.3 million in 2024, then surged by 43.65% to $105.3 million in 2025, then slipped by 16.48% to $87.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $87.9 million (Q1 2026), $105.3 million (Q4 2025), and $168.6 million (Q3 2025), per Business Quant data.

Peer Comparison